Avidity Biosciences (RNAM) - Market capitalization

Market cap: NZ$19.14 Billion

As of April 2026 Avidity Biosciences has a market cap of NZ$19.14 Billion. This makes Avidity Biosciences the world's 1842th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year	Marketcap	Change
2026	NZ$19.14 B

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Pfizer PFE	NZ$255.43 B	1,234.46%	🇺🇸 USA
GSK plc GSK	NZ$190.20 B	893.70%	🇬🇧 UK
Sarepta Therapeutics SRPT	NZ$3.53 B	-81.52%	🇺🇸 USA
PTC Therapeutics PTCT	NZ$9.75 B	-49.05%	🇺🇸 USA
Fate Therapeutics FATE	NZ$0.26 B	-98.64%	🇺🇸 USA
Acorda Therapeutics ACOR	NZ$1.39 M	-99.99%	🇺🇸 USA
Acceleron Pharma XLRN	NZ$18.60 B	-2.82%	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	NZ$5.59 B	-70.76%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Avidity Biosciences (RNAM)

Market cap: NZ$19.14 Billion